This inventor holds 1 USPTO granted patent. Top assignee: Triumf. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Alfred H Dougan: Innovator in Anticoagulant Research
Introduction
Alfred H Dougan is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of biomedical research, particularly in the development of anticoagulant therapies. His innovative work focuses on enhancing the effectiveness and longevity of therapeutic agents in the bloodstream.
Latest Patents
Alfred H Dougan holds a patent for a groundbreaking invention titled "Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood." This invention involves a complex of a polynucleotide that specifically binds to a target protein, combined with a protein that stabilizes the polynucleotide from degradation and clearance in vivo. The patent outlines methods for diagnostic imaging and therapeutic applications of this complex, showcasing its potential to improve patient outcomes.
Career Highlights
Dougan is currently associated with Triumf, a leading research institution known for its advancements in nuclear science and technology. His work at Triumf has allowed him to collaborate with other experts in the field, further enhancing the impact of his research.
Collaborations
One of his notable collaborators is Jeffrey I Weitz, a respected figure in the field of hematology. Together, they have worked on projects that aim to improve anticoagulant therapies and their applications in clinical settings.
Conclusion
Alfred H Dougan's contributions to the field of anticoagulant research are significant and impactful. His innovative patent and collaboration with esteemed colleagues highlight his dedication to advancing medical science. His work continues to pave the way for new therapeutic solutions in the healthcare industry.